Tauroursodeoxycholic Acid-d4 (sodium salt) Chemical Properties

storage temp. 

-20°C

solubility 

DMF: 25 mg/ml; DMSO: 20 mg/ml; Ethanol: 1 mg/ml; PBS (pH 7.2): 1 mg/ml

form 

A crystalline solid

color 

White to off-white

CAS Number Unlabeled

35807-85-3

Tauroursodeoxycholic Acid-d4 (sodium salt) Usage And Synthesis

Description

Tauroursodeoxycholic acid-d₄ (TUDCA-d₄) is intended for use as an internal standard for the quantification of tauroursodeoxycholic acid by GC- or LC-MS. TUDCA is a taurine-conjugated form of the secondary bile acid ursodeoxycholic acid .^1,2 TUDCA is found in small quantities in human bile but at a higher concentration in the bile of black bears.² It demonstrates anti-apoptotic activity in rodent models of tauopathy, Huntington's disease, ischemic brain injury, and retinal disorders.^3,2

Uses

Tauroursodeoxycholate-d4 (sodium) is the deuterium labeled Tauroursodeoxycholate sodium. Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.

References

1. Beuers, U. Effects of bile acids on hepatocellular signaling and secretion Yale J. Biol. Med. 70(4),341-346(1997).
2. Boatright, J.H., Nickerson, J.M., Moring, A.G., et al. Bile acids in treatment of ocular disease J. Ocul. Biol. Dis. Infor. 2(3),149-159(2009).
3. Vang, S., Longley, K., Steer, C.J., et al. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases Glob. Adv. Health Med. 3(3),58-69(2014).

Tauroursodeoxycholic Acid-d4 (sodium salt)(2410279-95-5)Related Product Information

• Taurodeoxycholic Acid-[d4] Sodium Salt
• 2-[[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt
• 2-[[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]amino]-ethanesulfonicacid,monosodiumsalt
• Taurolithocholic Acid-d5
• TAUROCHOLIC ACID-D4